According to the research report titled ‘Global Biosurgery Market 2021-2028’, available with Market Study Report, global biosurgery market is touted to witness a compound annual growth rate of 6.21% over the forecast period 2021-2028.
 

As per the report findings, factors such as innovations & technological advancements in healthcare, growing geriatric population, increasing number of surgeries for musculoskeletal ailments, and rising prevalence of joint reconstruction and spinal fusion procedures are the primary factors stimulating global biosurgery market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3977458/
 

Additionally, extensive research & investments in bioengineering sector, coupled with formulation of efficient reimbursement & compensation policies are creating new opportunities for businesses operating in this domain.
 

On the downside, escalating costs of surgeries, inclination towards minimally invasive procedures, and complexities relating to immune system response are likely to inhibit the market growth trajectory in the forthcoming years.
 

Based on product type, the industry is fragmented into hemostatic agents, surgical sealing agents (natural, synthetic), bone-graft substitutes (bone morphogenetic proteins, synthetic graft extenders, demineralized bone matrix, cell-based matrices), soft-tissue management (natural & synthetic mesh/patch), staple line reinforcement, and anti-adhesive agents.
 

Moving on to application scope, worldwide biosurgery market is classified into neuro & spine surgery, orthopedic surgery, general surgery, and cardio & thoracic surgery. By source type, the market fragmentation comprises synthetic, and natural variants.
 

From a regional frame of reference, the research literature deems Latin America, North America, Asia-Pacific, Middle East & Africa, and Europe to be key growth avenues in the industry. Among these, Asia-Pacific market is slated to generate substantial returns over the assessment period, owing to rising prevalence of chronic diseases, mounting demand for surgical procedures, and increasing development & launch of innovative products.
 

The competitive landscape of global biosurgery market is defined by companies such as Zimmer Biomet Holdings Inc., Wright Medical Group N.V., Stryker Corp., Smith & Nephew plc, Sanofi S.A., RTI Surgical Inc., Medtronic plc, Integra Lifesciences Holdings Corp., Ethicon Inc. (Johnson & Johnson), CSL Ltd., B. Braun Melsungen AG, Becton, Dickinson and Co., and Baxter International Inc.